FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090963139> ?p ?o ?g. }

• W2090963139 endingPage "174" @default.
• W2090963139 startingPage "168" @default.
• W2090963139 abstract "Previous pediatric studies have failed to demonstrate a clear association between protease inhibitor (PI) therapy and abnormal glucose homeostasis in HIV-infected children. To define more precisely the impact of PI therapy on glucose homeostasis in this population, we performed the insulin-modified frequent-sampling iv glucose tolerance test on 33 PI-treated and 15 PI-naive HIV-infected children. Other investigations included fasting serum lipids; glucose, insulin, and C-peptide; single-slice abdominal computed tomography; and, in a subset of PI-treated children, an oral glucose tolerance test. There were no differences between the two groups with respect to fasting serum insulin or C-peptide, homeostatic model assessment insulin resistance, or quantitative insulin sensitivity check index. The mean insulin sensitivity index of PI-treated and PI-naive children was 6.93 +/- 6.37 and 10.58 +/- 12.93 x 10(-4)min(-1) [microU/ml](-1), respectively (P = 0.17). The mean disposition index for the two groups was 1840 +/- 1575 and 3708 +/- 3005 x 10(-4)min(-1) (P = 0.013), respectively. After adjusting for potential confounding variables using multiple regression analysis, the insulin sensitivity index and disposition index of PI-treated children were significantly lower than that of PI-naive children (P = 0.01 for both). In PI-treated but not PI-naive children, insulin sensitivity correlated inversely with visceral adipose tissue area (r = -0.43, P = 0.01) and visceral to sc adipose tissue ratio (r = -0.49, P = 0.004). Mildly impaired glucose tolerance was noted in four of 21 PI-treated subjects tested. Our results demonstrate not only that PI therapy reduces insulin sensitivity in HIV-infected children but also that it impairs the beta-cell response to this reduction in insulin sensitivity and, in a subset of children, leads to the development of impaired glucose tolerance. The presence of insulin resistance, dyslipidemia, and the significant correlation of reduced insulin sensitivity with increased visceral adipose tissue content suggest that PI-containing highly active antiretroviral therapy is associated with the emergence of early features of a metabolic syndrome-like phenotype." @default.
• W2090963139 created "2016-06-24" @default.
• W2090963139 creator A5016809126 @default.
• W2090963139 creator A5017986343 @default.
• W2090963139 creator A5027393118 @default.
• W2090963139 creator A5028740151 @default.
• W2090963139 creator A5032533894 @default.
• W2090963139 creator A5060144182 @default.
• W2090963139 creator A5064592987 @default.
• W2090963139 creator A5074802270 @default.
• W2090963139 creator A5076991437 @default.
• W2090963139 date "2005-01-01" @default.
• W2090963139 modified "2023-09-27" @default.
• W2090963139 title "Insulin Sensitivity and β-Cell Function in Protease Inhibitor-Treated and -Naive Human Immunodeficiency Virus-Infected Children" @default.
• W2090963139 cites W1905082515 @default.
• W2090963139 cites W1965153851 @default.
• W2090963139 cites W1965561480 @default.
• W2090963139 cites W1976890976 @default.
• W2090963139 cites W1978444406 @default.
• W2090963139 cites W2004027480 @default.
• W2090963139 cites W2004927761 @default.
• W2090963139 cites W2005933532 @default.
• W2090963139 cites W2007061978 @default.
• W2090963139 cites W2007142745 @default.
• W2090963139 cites W2010352983 @default.
• W2090963139 cites W2015391533 @default.
• W2090963139 cites W2023480288 @default.
• W2090963139 cites W2033756224 @default.
• W2090963139 cites W2056243308 @default.
• W2090963139 cites W2058217770 @default.
• W2090963139 cites W2061309116 @default.
• W2090963139 cites W2061496424 @default.
• W2090963139 cites W2076768567 @default.
• W2090963139 cites W2080507282 @default.
• W2090963139 cites W2084627985 @default.
• W2090963139 cites W2096773810 @default.
• W2090963139 cites W2119886572 @default.
• W2090963139 cites W2126327417 @default.
• W2090963139 cites W2127283734 @default.
• W2090963139 cites W2130171861 @default.
• W2090963139 cites W2133795831 @default.
• W2090963139 cites W2135032077 @default.
• W2090963139 cites W2144227696 @default.
• W2090963139 cites W2156498401 @default.
• W2090963139 cites W2160234571 @default.
• W2090963139 cites W2162344377 @default.
• W2090963139 cites W2171589158 @default.
• W2090963139 cites W2330816455 @default.
• W2090963139 cites W2332812525 @default.
• W2090963139 cites W4238666664 @default.
• W2090963139 cites W4239823091 @default.
• W2090963139 doi "https://doi.org/10.1210/jc.2004-0125" @default.
• W2090963139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15483082" @default.
• W2090963139 hasPublicationYear "2005" @default.
• W2090963139 type Work @default.
• W2090963139 sameAs 2090963139 @default.
• W2090963139 citedByCount "41" @default.
• W2090963139 countsByYear W20909631392012 @default.
• W2090963139 countsByYear W20909631392013 @default.
• W2090963139 countsByYear W20909631392014 @default.
• W2090963139 countsByYear W20909631392016 @default.
• W2090963139 countsByYear W20909631392017 @default.
• W2090963139 countsByYear W20909631392018 @default.
• W2090963139 countsByYear W20909631392019 @default.
• W2090963139 crossrefType "journal-article" @default.
• W2090963139 hasAuthorship W2090963139A5016809126 @default.
• W2090963139 hasAuthorship W2090963139A5017986343 @default.
• W2090963139 hasAuthorship W2090963139A5027393118 @default.
• W2090963139 hasAuthorship W2090963139A5028740151 @default.
• W2090963139 hasAuthorship W2090963139A5032533894 @default.
• W2090963139 hasAuthorship W2090963139A5060144182 @default.
• W2090963139 hasAuthorship W2090963139A5064592987 @default.
• W2090963139 hasAuthorship W2090963139A5074802270 @default.
• W2090963139 hasAuthorship W2090963139A5076991437 @default.
• W2090963139 hasBestOaLocation W20909631391 @default.
• W2090963139 hasConcept C126322002 @default.
• W2090963139 hasConcept C134018914 @default.
• W2090963139 hasConcept C171089720 @default.
• W2090963139 hasConcept C2777391703 @default.
• W2090963139 hasConcept C2778535154 @default.
• W2090963139 hasConcept C2779306644 @default.
• W2090963139 hasConcept C2780833929 @default.
• W2090963139 hasConcept C2908647359 @default.
• W2090963139 hasConcept C3018667095 @default.
• W2090963139 hasConcept C63645605 @default.
• W2090963139 hasConcept C71924100 @default.
• W2090963139 hasConcept C99454951 @default.
• W2090963139 hasConceptScore W2090963139C126322002 @default.
• W2090963139 hasConceptScore W2090963139C134018914 @default.
• W2090963139 hasConceptScore W2090963139C171089720 @default.
• W2090963139 hasConceptScore W2090963139C2777391703 @default.
• W2090963139 hasConceptScore W2090963139C2778535154 @default.
• W2090963139 hasConceptScore W2090963139C2779306644 @default.
• W2090963139 hasConceptScore W2090963139C2780833929 @default.
• W2090963139 hasConceptScore W2090963139C2908647359 @default.
• W2090963139 hasConceptScore W2090963139C3018667095 @default.
• W2090963139 hasConceptScore W2090963139C63645605 @default.
• W2090963139 hasConceptScore W2090963139C71924100 @default.

• next